摘要整理

簡介

傳統的血糖監測系統與糖尿病管理市場

持續的血糖監測系統及感測器市場

簡介

產品案例

市場分析

各產品區隔市場

各地區市場

課題與趨勢

概要

新的技術創新

償付課題

回收

高齡化

對壽命的延長和最新醫療服務遞送方法的需求

醫療支出趨勢

感測器的進步

資料管理和電子病歷 其他

全球血糖監測系統及糖尿病管理市場，競爭分析

概要

推動市場因素和阻礙因素

全球市場規模與預測

各地區市場分析

企業簡介

圖表

目錄

Product Code: KLI5687926

Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, and complications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.

This Kalorama information report, The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaksout the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in. The report includes estimates and forecasts for the following segments:

Traditional Glucose Monitoring Devices

Meters

Test Strips

Lancets

Glycated Hemoglobin Devices

Continuous Glucose Monitoring Devices

Transmitters/Receivers

Sensors

HbA1c and other Market

There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.

In this global report, Kalorama identifies market size and forecast for Traditional Glucose Monitoring and Continuous Glucose Monitoring (CGM) both worldwide and for the following countries and regions:

United States

Germany

France

Italy

UK

Japan

Brazil

Russia

India

China

Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market. A select few are discussed here, including:

Abbott Laboratories

AgaMatrix

Arkray, Inc

Bayer Diabetes

Bionime Corporation

DexCom, Inc.

Echo Therapeutics

Entra Health Systems LLC

Fora Care, Inc

Genesis Health Technologies

GlySure Limited

Insulet

Johnson & Johnson

Medtronic

Nipro Diagnostics, Inc

Nova Diabetes Care, Inc.

Oak Tree International Holdings, Inc.

Prodigy Diabetes Care, LLC

Roche

U.S. Diagnostics, Inc.

Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 14 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with company representatives included marketing directors, division managers, and product representatives.

Additionally, Kalorama Information has nearly a decade of compiled industry contacts, technology knowledge and industry experience reporting on the patient management market segment, a market with parallel industry dynamics.Secondary sources such as company literature, databases, investment reports, and medical, information technology and business journals were used to complement primary information. Databases covering patient billings and units sold were significant resources for validating primary findings.

Table of Contents

EXECUTIVE SUMMARY

Market Overview

Scope and Methodology

Size and Growth of the Market

Market Participants

INTRODUCTION

Overview

Regulation of Glucose Metabolism

Hormone Regulation

Exercise

Stress

Etiology

Type I

Type 2

Gestational

Others

Risk Factors

Diagnostic Tests

Fasting Blood Sugar (FBS)

2-Hour Postprandial Blood Sugar (PPBS)

Random Blood Sugar

Glucose Tolerance Test

Glucose Urine Test

Glycated Hemoglobin (HbA1c)

Demographics

Population Growth

Global Population Trends

Aging of the Population

Global Population over 65

Diabetes Incidence and Prevalence

Global Impact of Diabetes

United States and Canada

Diabetes in Europe

Diabetes in Africa, Middle East, Asia Pacific

Diabetes in Latin America

Obesity

New Diabetes Monitoring Technologies

Wireless Technologies

Smartphones in Healthcare

Benefits of Healthcare Smartphones

Challenges in the Implementation of Smartphones in Healthcare Settings

Remote Monitoring

Cloud-Based Mobile Healthcare

Cloud Connectivity and Compatibility

EMR (EHR) Data Transfer Applications and Equipment

Technology Innovation

Technology for Drug Adherence, Targeted Delivery, and Monitoring

Mobile Medical Applications and Patient Monitoring

Apps for Diabetes Management

TRADITIONAL GLUCOSE MONITORING DEVICES AND DIABETES MANAGEMENT MARKET

Traditional Glucose Monitoring Devices and Diabetes Management

Overview

Glucose Meters, Test Strips and Lancets

Selected Product Examples

Glycated Hemoglobin

Selected Product Examples

New Product Innovations

Market Analysis

Markets by Product Segment

Markets by Application

Self-Testing

Professional Testing

Markets by Global Region

United States

Europe

Japan

Rest of World

Competitive Analysis

CONTINUOUS GLUCOSE MONITORING AND SENSOR MARKET

Introduction

Selected Product Examples

Market Analysis

Markets by Product Segment

Markets by Global Region

United States

Europe

Japan

Rest of World

Competitive Analysis

ISSUES AND TRENDS

Overview

New Innovations

Reimbursement Challenges

Recalls

Aging of the Population

Increasing Life Expectancy and the Demand for Advanced Healthcare Delivery